Search Results - "Frederix, G"

Economic evaluations in medical technological innovations a mapping review of methodologies by van Lieshout, C, Frederix, G W J, Schoonhoven, L

“…Economic evaluations play an important role in the development and implementation of healthcare innovations. For pharmaceutical products, the methodologies…”
Get full text

Congenital anomalies and genetic disorders in neonates and infants: a single-center observational cohort study by Marouane, A., Olde Keizer, R. A. C. M., Frederix, G. W. J., Vissers, L. E. L. M., de Boode, W. P., van Zelst-Stams, W. A. G.

“…Neonates with genetic disorders or congenital anomalies (CA) contribute considerably to morbidity and mortality in neonatal intensive care units (NICUs). The…”
Get full text

Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective by Bokkers, K., Frederix, G.W.J., Velthuizen, M.E., van der Aa, M., Gerestein, C.G., van Dorst, E.B.L., Lange, J.G., Louwers, J.A., Koole, W., Zweemer, R.P., Ausems, M.G.E.M.

“…OBJECTIVEGermline genetic testing is increasingly offered to patients with epithelial ovarian cancer by non-genetic healthcare professionals, so called…”
Get full text

Paravertebral catheter versus EPidural analgesia in Minimally invasive Esophageal resectioN: a randomized controlled multicenter trial (PEPMEN trial) by Kingma, B F, Eshuis, W J, de Groot, E M, Feenstra, M L, Ruurda, J P, Gisbertz, S S, Ten Hoope, W, Marsman, M, Hermanides, J, Hollmann, M W, Kalkman, C J, Luyer, M D P, Nieuwenhuijzen, G A P, Scholten, H J, Buise, M, van Det, M J, Kouwenhoven, E A, van der Meer, F, Frederix, G W J, Cheong, E, Al Naimi, K, van Berge Henegouwen, M I, van Hillegersberg, R

“…Thoracic epidural analgesia is the standard postoperative pain management strategy in esophageal cancer surgery. However, paravertebral block analgesia may…”
Get full text

Cost-effectiveness of a multidisciplinary lifestyle-enhancing treatment for inpatients with severe mental illness: the MULTI study V by Deenik, J., Van Lieshout, C., Van Driel, H., Frederix, G., Hendriksen, I., Van Harten, P., Tenback, D.

“…Introduction Economic evaluations of lifestyle interventions for people with mental illness are needed to inform policy makers and managers about implementing…”
Get full text

Rationale and design of the iCORONARY trial: improving the cost-effectiveness of coronary artery disease diagnosis by Peper, J., Becker, L. M., Bruning, T. A., Budde, R. P. J., van Dockum, W. G., Frederix, G. W. J., Habets, J., Henriques, J. P. S., Houthuizen, P., Mohamed Hoesein, F. A. A., Planken, R. N., Voskuil, M., Bots, M. L., Leiner, T., Swaans, M. J.

“…Background In patients with stable coronary artery disease (CAD), revascularisation decisions are based mainly on the visual grading of the severity of…”
Get full text

Changing costs of metastatic non small cell lung cancer in the Netherlands by Keusters, W.R., de Weger, V.A., Hövels, A., Schellens, J.H.M., Frederix, G.W.J.

“…•A Cost of illness study on non-small cell lung cancer is conducted.•Cost on non-small cell lung cancer have decreased in recent years.•Oncolytic drugs have…”
Get full text

Realizing the value of complex medical technology: Demonstrating cost-effectiveness is not enough by Hehakaya, C., Frederix, G.W.J., van der Voort van Zyp, J.RN, Grobbee, D.E., Verkooijen, H.M.

“…•Engaging stakeholders before implementing the complex medical technology is important to promote its relevance, usefulness and effectiveness from multiple…”
Get full text

Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial by van Dooijeweert, C, Flach, R N, Ter Hoeve, N D, Vreuls, C P H, Goldschmeding, R, Freund, J E, Pham, P, Nguyen, T Q, van der Wall, E, Frederix, G W J, Stathonikos, N, van Diest, P J

“…Pathologists' assessment of sentinel lymph nodes (SNs) for breast cancer (BC) metastases is a treatment-guiding yet labor-intensive and costly task because of…”
Get full text

Time-dependent resource use and costs associated with different states of disease in patients diagnosed with HER-2-positive metastatic breast cancer by Frederix, G. W. J., Severens, J. L., Hövels, A. M., van Hasselt, J. G. C., Raaijmakers, J. A. M., Schellens, J. H. M.

“…Adequate reflection of disease progression and costs over time is essential in cost-effectiveness analyses based on health state-transition models. However,…”
Get full text

Author Correction: Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial by van Dooijeweert, C, Flach, R N, Ter Hoeve, N D, Vreuls, C P H, Goldschmeding, R, Freund, J E, Pham, P, Nguyen, T Q, van der Wall, E, Frederix, G W J, Stathonikos, N, van Diest, P J

Get full text

DPYD genotype-guided dose individualization of fluoropyrimidine therapy: A prospective safety and cost-analysis on DPYD variants DPYD2A, c.2846A>T, c.1679T>G and c.1236G>A by Henricks, L M, Lunenburg, C A T C, de Man, F M, Meulendijks, D, Frederix, G W J, Kienhuis, E, Creemers, G-J M, Baars, A, Dezentjé, V O, Rosing, H, Beijnen, J H, van Werkhoven, E, van Kuilenburg, A B P, van Schaik, R H N, Mathijssen, R H J, Swen, J J, Gelderblom, H, Cats, A, Guchelaar, H-J, Schellens, J H M

Get full text

Finding Salient Regions in Images: Nonparametric Clustering for Image Segmentation and Grouping by Pauwels, E.J, Frederix, G

“…A major problem in content-based image retrieval (CBIR) is the unsupervised identification of perceptually salient regions in images. We contend that this…”
Get full text

Real world cost of human epidermal receptor 2-positive metastatic breast cancer patients: a longitudinal incidence-based observational costing study in the Netherlands and Belgium by Frederix, G.W.J., Severens, J.L., Hövels, A.M., van Hasselt, J.G.C., Hooiveld, M.J.J., Neven, P., Raaijmakers, J.A.M., Schellens, J.H.M.

“…Currently, no country‐specific metastatic breast cancer (MBC) observational costing data are available for the Netherlands and Belgium. Our aim is to describe…”
Get full text

Aerobic interval training and continuous training equally improve aerobic exercise capacity in patients with coronary artery disease: the saintex-cad study by Beckers, P, Vanhees, L, Pattyn, N, De Maeyer, C, Coeckelberghs, E, Frederix, G, Goetschalckx, K, Van Craenenbroeck, E, Cornelissen, V.A, Conraads, V

Get full text

Assessment of Validation of Health-Economics Decision Models In Intervention Studies of Seasonal Influenza and Breast Cancer by de Boer, PT, Frederix, GW, Al, MJ, Feenstra, TF, Vemer, P

Get full text

Reimbursement of Orphan and Expensive Drugs In The Netherlands: Exploration of Essential Criteria In The Decision Making Process by Tariq, L, Frederix, GW, Roberts, RW, van Bakel, P, Belitser, SV, Raaijmakers, JA, Hövels, AM

Get full text

Decrease of Patient Costs in the Netherlands: a Cost of Illness Study in Metastatic Non Small Cell Lung Cancer (Nsclc) by Keusters, WR, Frederix, GW, de Weger, VA, Beijnen, JH, Hövels, AM, Schellens, JH

Get full text

PSY142 - THE ACCESS (TIMING AND AVAILABILITY) OF ORPHAN MEDICINE USE AND ITS DETERMINANTS AMONG OECD COUNTRIES FROM 2006 THROUGH 2016 by Pyo, J., Frederix, G., Hovels, A.M.

Get full text

Clinical utility of whole-genome sequencing in precision oncology by Rosenquist, Richard, Cuppen, Edwin, Buettner, Reinhard, Caldas, Carlos, Dreau, Helene, Elemento, Olivier, Frederix, Geert, Grimmond, Sean, Haferlach, Torsten, Jobanputra, Vaidehi, Meggendorfer, Manja, Mullighan, Charles G., Wordsworth, Sarah, Schuh, Anna

“…Precision diagnostics is one of the two pillars of precision medicine. Sequencing efforts in the past decade have firmly established cancer as a primarily…”
Get full text